Endocrinology
Obese women with polycystic ovary syndrome benefit from naltrexone treatment
Published in Women's Health Weekly, August 1st, 2002
Franca Fruzzetti and colleagues at the University of Pisa performed an open, controlled clinical trial to determine the effects of naltrexone therapy on obese women with polycystic ovary syndrome (PCOS). The study involved 10 women who received 6 months of naltrexone (50 mg/day) therapy.
Women underwent testing for basal levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), 17beta-estradiol (E2 ), 17-hydroxyprogesterone,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer Therapy
Interferon and endostatin gene therapy outpace angiostatin in breast cancers - Labor and Delivery
Continuous stitching method reduces pain for women with perineal damage after childbirth - Breast Cancer
Importance of early environmental exposure pinpointed - Cervical Cancer
Tissue changes may explain false-negative Pap smears - Menopause
Hormone therapy offers no protection against heart attacks - Obstetrics
Cesareans could make it more difficult to have other children - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
